St. Jude expands strategic plan to target pediatric catastrophic diseases

NLRC5 is an innate immune sensor that plays a crucial role in PANoptotic cell death

NLRC5 plays a previously unknown role as an innate immune sensor, triggering cell death, according to new research from St. Jude Children’s Research Hospital. The findings, published in Cell, show how NLRC5 drives PANoptosis, a prominent type of inflammatory cell death.

June 21, 2024

Vol.50 No.25

Clinical Roundup

T-cell aging not limited by organismal age, allowing healthy cells to proliferate in perpetuity

While most cell types experience a functional decline after years of proliferation and replication, T cells can proliferate seemingly indefinitely and without detriment.

June 14, 2024

Vol.50 No.24

In Brief

Andrew Smith named chair of St. Jude Diagnostic Imaging Department

Andrew Smith was named chair of St. Jude’s Diagnostic Imaging Department. He succeeds Beth McCarville, who was interim chair of the department since the death of Zoltan Patay, who held the position from 2017 to 2022.

April 19, 2024

Vol.50 No.16

In Brief

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

The UF Health Proton Therapy Institute enhanced its playroom, a respite for its pediatric patients, significantly with innovative technology that promotes therapeutic engagement, with an 86” interactive gaming wall that features educational and sensory software.

March 29, 2024

Vol.50 No.13

Clinical Roundup

USC researchers find genetic variant contributing to disparities in childhood leukemia risk

Researchers from the University of Southern California found a genetic variant contributing to disparities in childhood leukemia risk. The variant, located on the IKZF1 gene, helps explain why Hispanic/Latino children face a higher risk of acute lymphoblastic leukemia and offers insights about what causes the disease.

March 29, 2024

Vol.50 No.13

In Brief

Fox Chase’s Joshua Cohn named consultant to Shriners Children’s Philadelphia

Joshua Cohn, associate professor in the Department of Urology at Fox Chase Cancer Center and a member of the Fox Chase – Temple Urologic Institute, was named a consultant at Shriners Children’s Philadelphia.

February 16, 2024

Vol.50 No.07

St. Jude expands strategic plan to target pediatric catastrophic diseases

YOU MAY BE INTERESTED IN

NLRC5 is an innate immune sensor that plays a crucial role in PANoptotic cell death

T-cell aging not limited by organismal age, allowing healthy cells to proliferate in perpetuity

Andrew Smith named chair of St. Jude Diagnostic Imaging Department

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

USC researchers find genetic variant contributing to disparities in childhood leukemia risk

Fox Chase’s Joshua Cohn named consultant to Shriners Children’s Philadelphia

Renew today!

Subscriber content

Login